USPTO Examiner RIVERS LINDSEY RAE - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18584180PROXIMAL LINK WIRE FOR PREVENTING PREMATURE IMPLANT DETACHMENTFebruary 2024March 2025Allow1310YesNo
18431353HOOK WIRE FOR PREVENTING PREMATURE EMBOLIC IMPLANT DETACHMENTFebruary 2024August 2024Allow700YesNo
18426045HALF PIPE CANNULA AND METHODS OF MANUFACTURING AND USING HALF PIPE CANNULAJanuary 2024March 2025Allow1310YesNo
18399294KNOTLESS ANCHOR INSERTIONDecember 2023March 2025Allow1410YesNo
18483807ROBOTICALLY AND MANUALLY OPERABLE UTERINE MANIPULATORSOctober 2023March 2025Allow1720YesNo
18337204MEDICAL DEVICE AND PROCEDURE METHODJune 2023April 2025Allow2210YesNo
17792506SURGICAL INSTRUMENTS HAVING A ROTATABLE BLADE MEMBER FOR TREATING TISSUEJuly 2022May 2025Abandon3511NoNo
17806123TISSUE-REMOVING CATHETER WITH A COUPLED INNER LINERJune 2022October 2024Allow2800YesNo
17783568APPARATUS AND METHOD FOR PIERCING A SOFT TISSUE CANAL IN A BODY PART AND IMPLANT FOR INSERTION INTO A SOFT TISSUE CANAL IN A BODY PARTJune 2022February 2025Abandon3210NoNo
17777430HEMOSTATIC CLIP AND AUXILIARY SYSTEMMay 2022March 2025Abandon3410NoNo
17662924REPOSITIONAL CLIP WITH EXTENSIONMay 2022September 2024Allow2800YesNo
17737589CLAMP FORCE CONTROL FEATURE FOR SURGICAL END EFFECTORMay 2022May 2025Allow3620YesNo
17693516PROXIMAL LINK WIRE FOR PREVENTING PREMATURE IMPLANT DETACHMENTMarch 2022August 2023Allow1700YesNo
17641456SYSTEM AND METHOD FOR TEMPORARILY STOPPING BLOOD FLOW THROUGH A BLOOD VESSELMarch 2022January 2025Abandon3410NoNo
17685147HOOK WIRE FOR PREVENTING PREMATURE EMBOLIC IMPLANT DETACHMENTMarch 2022August 2023Allow1700YesNo
17685323MEDICAL DEVICEMarch 2022April 2025Allow3720YesNo
17683437MEDICAL DEVICEMarch 2022March 2025Allow3711YesNo
17682831NEEDLE ASSEMBLY FOR LIQUID APPLICATORFebruary 2022December 2024Allow3411YesNo
17677934VASO-OCCLUSIVE DEVICES INCLUDING A FRICTION ELEMENTFebruary 2022July 2025Allow4021YesNo
17676049PUNCTURE NEEDLESFebruary 2022June 2025Allow4021YesNo
17671409TISSUE-REMOVING CATHETER WITH INNER LINER KEYFebruary 2022October 2024Allow3210YesNo
17650316ADJUSTABLE LOCKING HANDLE DESIGN FOR DEBRIDERSFebruary 2022July 2024Allow2921YesNo
17592776SUTURING BREAKAWAY ANCHOR STRIPFebruary 2022January 2024Allow2420YesNo
17586032MEDICAL DEVICE FOR CLOSURE OF A VASCULAR ABNORMALITYJanuary 2022May 2024Allow2821YesNo
17583887SHEATH FOR CATHETER LENGTH ADJUSTMENTJanuary 2022February 2024Allow2420YesNo
17629363SUTURE PASSERSJanuary 2022February 2025Abandon3710NoNo
17625657GRADUALLY RESTRICTING VASCULAR BLOOD FLOWJanuary 2022November 2023Allow2210NoNo
17562733METHOD FOR CLOSING WOUNDDecember 2021November 2023Allow2320YesNo
17553461CLIP DELIVERY DEVICEDecember 2021February 2024Allow2620NoNo
17617645MEDICAL TOOL WITH LENGTH CONSERVATION MECHANISM FOR ACTUATING TENSION BANDSDecember 2021October 2024Allow3501YesNo
17617260BALLOON FOR EXPANDING AN ORIFICEDecember 2021April 2025Allow4020YesNo
17544696DEVICE, METHOD AND SYSTEM FOR RESHAPING A HEART VALVE ANNULUSDecember 2021October 2024Allow3410YesNo
17610820SYSTEMS AND METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTIONNovember 2021October 2024Allow3510YesNo
17478081INVERTING BRAIDED ANEURYSM IMPLANT WITH DOME FEATURESeptember 2021March 2024Allow3021YesNo
17440692ORGAN RESECTION STUMP FIXING CLIPSeptember 2021October 2024Abandon3710NoNo
17460950FLOW BLOCKING CATHETERAugust 2021April 2024Abandon3220NoNo
17404600DEVICES, SYSTEMS, AND METHODS FOR ANCHORING TISSUEAugust 2021June 2025Allow4650YesNo
17444502MEDICAL DEVICE DELIVERY DEVICES, SYSTEMS, AND METHODSAugust 2021January 2024Allow2901YesNo
17390315MEDICAL STENTSJuly 2021December 2024Abandon4140NoNo
17312941KnotterJune 2021January 2025Allow4320YesNo
17311897STENT DEVICEJune 2021July 2024Allow3730YesNo
17306039DELIVERY SYSTEM FOR PROSTHETIC VALVE DEVICE HAVING CONTROLLED RELEASE OF INFLOW AND OUTFLOW ENDSMay 2021February 2024Allow3421YesNo
17245332VARIABLE JAW CLOSURE OF A ROBOTIC SURGICAL SYSTEMApril 2021November 2023Allow3011YesNo
17309135SYSTEM FOR CONNECTING A MEDICAL IMPLANT TO AN INSERTION AIDApril 2021November 2023Allow3010YesNo
17241392KNOTLESS SUTURE ANCHORSApril 2021December 2023Allow3220YesNo
17241296KNOTLESS ANCHOR INSERTIONApril 2021September 2023Allow2920YesNo
17235687ENDOSCOPE CLIPApril 2021November 2024Allow4311YesNo
17221641Releasable Delivery SystemApril 2021November 2023Allow3110YesNo
17220013RATCHET TOURNIQUET FOR CARDIOPULMONARY RESUSCITATIONApril 2021October 2023Abandon3011NoNo
17275347KISSING BALLOONSMarch 2021October 2023Allow3110YesNo
17191846SNAP-FIT TRANSVAGINAL OCCLUDERMarch 2021April 2024Abandon3820NoNo
17183508Medical Device for AnastomosisFebruary 2021June 2023Allow2710YesNo
17172222ROBOTICALLY AND MANUALLY OPERABLE UTERINE MANIPULATORSFebruary 2021June 2023Allow2920NoNo
17248739CATHETER-BASED MEDICAL DEVICE FOR OCCLUDING THE AORTIC FALSE LUMEN AFTER AN AORTIC DISSECTIONFebruary 2021August 2023Abandon3010NoNo
17163140HALF PIPE CANNULA AND METHODS OF MANUFACTURING AND USING HALF PIPE CANNULAJanuary 2021October 2023Allow3330YesNo
17152354ATHERECTOMY MOTOR CONTROL SYSTEM WITH TACTILE FEEDBACKJanuary 2021November 2023Allow3400YesNo
17150197TISSUE RESECTING INSTRUMENTJanuary 2021June 2023Abandon2910NoNo
17143015System and Methods for Treating a BifurcationJanuary 2021August 2023Allow3101YesNo
17257316HEADGEAR WITH STIMULATION ELEMENTS AND RELATED METHODDecember 2020June 2024Abandon4210NoNo
17136573ANTI-HEMORRHAGE DEVICE WITH RIGID BACK PLATEDecember 2020February 2024Allow3830NoNo
17252704TOURNIQUET WITH USER-SELECTABLE SAFETY PROTOCOLSDecember 2020February 2024Allow3810NoNo
16973564Reference Navigation Equipment in Robotic Surgery Assisted by Stereotaxic Navigation of the Organs and Soft Parts of a Patient's Pelvic AreaDecember 2020March 2024Abandon3910NoNo
17108836EMBOLIC PROTECTION DEVICEDecember 2020January 2024Abandon3710NoNo
17090707SHUTTLE CABLE TRANSPORTING DEVICE AND METHODNovember 2020August 2024Abandon4511NoNo
16988122MANUAL END EFFECTOR ACTIVATION FOR ROBOTIC SURGICAL SYSTEMSAugust 2020November 2023Allow3920YesNo
16935808TROCAR SYSTEM WITH FORCE SENSINGJuly 2020February 2024Abandon4220YesNo
16932665ARCHITECTURE FOR OPTIMIZING RANGE OF MOTION OF TWO ROBOTIC ARMS IN A ROBOTIC SURGICAL SYSTEMJuly 2020May 2025Abandon5840NoNo
16919168SURGICAL STAPLING DEVICEJuly 2020March 2024Abandon4410YesNo
16909660DEVICE AND METHOD FOR TREATMENT OF HEMORRHOIDS USING SUCTIONJune 2020June 2024Allow5021YesNo
16834555BALLOON CATHETER SUTURING SYSTEMS, METHODS, AND DEVICES HAVING PLEDGETSMarch 2020July 2023Allow4000YesNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner RIVERS, LINDSEY RAE - Prosecution Strategy Guide

Executive Summary

Examiner RIVERS, LINDSEY RAE works in Art Unit 3771 and has examined 67 patent applications in our dataset. With an allowance rate of 71.6%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner RIVERS, LINDSEY RAE's allowance rate of 71.6% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by RIVERS, LINDSEY RAE receive 1.45 office actions before reaching final disposition. This places the examiner in the 33% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by RIVERS, LINDSEY RAE is 34 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +72.8% benefit to allowance rate for applications examined by RIVERS, LINDSEY RAE. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 43.8% of applications are subsequently allowed. This success rate is in the 95% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 33.3% of cases where such amendments are filed. This entry rate is in the 42% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 5% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 42% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 41% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.